Get startedLog in
    Picture of Soleno Therapeutics logo

    SLNO — Soleno Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapFalling Star
    All News

    Brief: Soleno Therapeutics Announces Preliminary Financial And Operational Results for Q2

    Picture of Soleno Therapeutics logoSoleno Therapeutics
    10/07/2025 11:49
    July 10 (Reuters) - Soleno Therapeutics Inc SLNO.O:

SOLENO THERAPEUTICS ANNOUNCES PRELIMINARY FINANCIAL AND OPERATIONAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2025

SOLENO THERAPEUTICS: EXPECTS NET REVENUE FROM SALES OF VYKAT(TM) XR, FOR THREE MONTHS ENDED JUNE TO BE BETWEEN $31.0 MILLION - $33.0 MILLION

Source text: ID:nGNX39yDxp

Further company coverage: SLNO.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Soleno Therapeutics

    See all news